President Donald Trump on Tuesday announced that the University of Miami had agreed to let the US. Food and Drug Administration use a psychodelic drug's original application to help streamline research and development.

"In April, I signed a very important Executive Order to accelerate medical treatments for serious mental illness — Specifically, psychedelic drugs, including IBOGAINE," he posted on Truth Social. "This is something that has helped so many of our amazing VETERANS and true American Heroes who were here in the Oval Office with me, and Joe Rogan."

"Today I am announcing that Secretary Kennedy has received a Historic Gift from the University of Miami, who has given the Federal Government its original 1994 Ibogaine Investigational New Drug application," he added. "This will give everyone direct access to the foundational FDA authorization to accelerate its development as a medical treatment in the U.S. This is HUGE! Special THANK YOU to the University of Miami, who has done this to ensure that Americans are helped as quickly as possible."

The gift comes in the wake of Trump's April executive order meant to streamline research into key drugs and to allow patients to take experimental medications under "right to try."

Ben Whedon is the Chief Political Correspondent for Just the News. Follow him on X.